BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Novacek G, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Vogelsang H, Dejaco C, Waldhör T; Austrian IBD Study Group (ATISG). Diagnostic delay in patients with inflammatory bowel disease in Austria. Wien Klin Wochenschr 2019;131:104-12. [PMID: 30715607 DOI: 10.1007/s00508-019-1451-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Apine I, Pitura R, Franckevica I, Pokrotnieks J, Krumina G. Comparison between Diffusion-Weighted Sequences with Selective and Non-Selective Fat Suppression in the Evaluation of Crohn's Disease Activity: Are They Equally Useful? Diagnostics (Basel) 2020;10:E347. [PMID: 32471191 DOI: 10.3390/diagnostics10060347] [Reference Citation Analysis]
2 Ricciuto A, Mack DR, Huynh HQ, Jacobson K, Otley AR, deBruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Jantchou P, Seidman EG, Carman N, Rashid M, Muise A, Wine E, Carroll MW, Lawrence S, Van Limbergen J, Benchimol EI, Walters TD, Griffiths AM, Church PC. Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease. J Crohns Colitis 2021;15:419-31. [PMID: 32978629 DOI: 10.1093/ecco-jcc/jjaa197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kutschera M, Waldhör T, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Peters PG, Reicht G, Moser G, Dejaco C, Vogelsang H, Primas C, Novacek G, Miehsler W; Austrian IBD Study Group. Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease. United European Gastroenterol J 2021;9:72-81. [PMID: 32723070 DOI: 10.1177/2050640620946874] [Reference Citation Analysis]
4 Gröchenig HP, Waldhör T, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Kutschera M, Dejaco C, Vogelsang H, Novacek G; Austrian IBD Study Group (ATISG). Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2019;31:1211-9. [PMID: 31498280 DOI: 10.1097/MEG.0000000000001533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Schoepfer A, Vavricka SR, Brüngger B, Blozik E, Bähler C. Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland. Eur J Gastroenterol Hepatol 2020;32:350-7. [PMID: 31834046 DOI: 10.1097/MEG.0000000000001616] [Reference Citation Analysis]
6 Molander P, Ylänne K. Impact of ulcerative colitis on patients’ lives: results of the Finnish extension of a global ulcerative colitis narrative survey. Scandinavian Journal of Gastroenterology 2019;54:869-75. [DOI: 10.1080/00365521.2019.1635637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Yamamoto-furusho JK, Parra-holguín NN. Diagnostic Delay of Inflammatory Bowel Disease Is Significantly Higher in Public versus Private Health Care System in Mexican Patients. Inflamm Intest Dis. [DOI: 10.1159/000520522] [Reference Citation Analysis]
8 Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M. Diagnosis and natural history of preclinical and early inflammatory bowel disease. Ann Gastroenterol 2020;33:443-52. [PMID: 32879589 DOI: 10.20524/aog.2020.0508] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]